Only rheumatoid factor‐positive subset of anti‐citrullinated peptide/protein antibody‐negative rheumatoid arthritis may seroconvert to anti‐citrullinated peptide/protein antibody‐positive

Anti‐citrullinated peptide/protein antibody (ACPA) has been reported to occur in about 60% of patients with early rheumatoid arthritis (RA), and about 80% in patients with established RA. While ACPA seroconversion is possible, previous reports have shown that it rarely occurs. We retrospectively determined the proportion of patients who underwent ACPA seroconversion and described the clinical characteristics of these cases.

[1]  K. Matsuo,et al.  ACPA-Negative RA Consists of Two Genetically Distinct Subsets Based on RF Positivity in Japanese , 2012, PloS one.

[2]  D. M. van der Heijde,et al.  Should Anti-citrullinated Protein Antibody and Rheumatoid Factor Status Be Reassessed During the First Year of Followup in Recent-Onset Arthritis? A Longitudinal Study , 2011, The Journal of Rheumatology.

[3]  S. Heath,et al.  Myelin Basic Protein as a Novel Genetic Risk Factor in Rheumatoid Arthritis—A Genome-Wide Study Combined with Immunological Analyses , 2011, PloS one.

[4]  J. Sterne,et al.  Systematic Review: Accuracy of Anti–Citrullinated Peptide Antibodies for Diagnosing Rheumatoid Arthritis , 2010, Annals of Internal Medicine.

[5]  B. Dijkmans,et al.  Different properties of ACPA and IgM-RF derived from a large dataset: further evidence of two distinct autoantibody systems , 2009, Arthritis research & therapy.

[6]  T. Matsui,et al.  Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis. , 2006, The Journal of rheumatology.

[7]  M. Dougados,et al.  Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis , 2006, Arthritis research & therapy.

[8]  R. Caporali,et al.  Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment , 2004, Arthritis research & therapy.

[9]  J. Sibilia,et al.  Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases , 2004, Annals of the rheumatic diseases.

[10]  B. Dijkmans,et al.  Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. , 2004, Arthritis and rheumatism.

[11]  Göran Hallmans,et al.  Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. , 2003, Arthritis and rheumatism.

[12]  D. Kimpel.  Meta-analysis: Diagnostic Accuracy of Anti–Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor for Rheumatoid Arthritis , 2008 .